Vitreous and plasma cytokine levels in subjects with advanced proliferative diabetic retinopathy in the Ranibizumab in Diabetic Vitrectomy (RaDiVit) Study

Comyn Oliver; Lange Clemens; Bainbridge James W. B.

首页> 外文期刊>Investigative ophthalmology & visual science >Vitreous and plasma cytokine levels in subjects with advanced proliferative diabetic retinopathy in the Ranibizumab in Diabetic Vitrectomy (RaDiVit) Study

【24h】

Vitreous and plasma cytokine levels in subjects with advanced proliferative diabetic retinopathy in the Ranibizumab in Diabetic Vitrectomy (RaDiVit) Study

机译：在糖尿病玻璃体型（Radivit）研究中具有晚期增殖性糖尿病视网膜病变的玻璃体和血浆细胞因子水平

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2019年第9期|共2页
作者
Comyn Oliver; Lange Clemens; Bainbridge James W. B.;
展开▼
作者单位

Moorfields Eye Hosp NHS Fdn Trust London England;

Moorfields Eye Hosp NHS Fdn Trust London England;

Moorfields Eye Hosp NHS Fdn Trust London England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Vitreous and plasma cytokine levels in subjects with advanced proliferative diabetic retinopathy in the Ranibizumab in Diabetic Vitrectomy (RaDiVit) Study [J] . Comyn Oliver, Lange Clemens, Bainbridge James W. B. Investigative ophthalmology & visual science . 2019,第9期

机译：在糖尿病玻璃体型（Radivit）研究中具有晚期增殖性糖尿病视网膜病变的玻璃体和血浆细胞因子水平
2. Day Regimes of CONbercept on CytokinEs of PDR Patients Undergoing Vitrectomy Trial (CONCEPT):Effects of preoperativeintravitreal conbercept on cytokines in the vitreous with proliferative diabetic retinopathy [J] . Liu Qinghuai, Xie Ping, Yuan Songtao, Investigative ophthalmology & visual science . 2019,第9期

机译：玻璃体术试验中PRT患者细胞因子的日躯体术（概念）：ProperativeIntravitaveal Conbercept对增殖性糖尿病视网膜病变玻璃体细胞因子的影响
3. Blood and vitreous humor cytokine profile in patients with proliferative diabetic retinopathy and post-vitrectomy hemophthalmia [J] . Путиенко Алексей Алексеевич, Погорелый Дмитрий Николаевич Kazan Medical Journal . 2013,第1期

机译：增生性糖尿病视网膜病变和玻璃体切除术后出血性眼病患者的血液和玻璃体液细胞因子谱
4. Outcomes of combination treatments in refractory neovascular glaucoma. A retrospective review in patients with advanced proliferative diabetic retinopathy [C] . Ramoa R., Juberfas J.R., Manzanas L, International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：难治性新生血管青光眼组合治疗的结果。晚期增殖性糖尿病视网膜病变患者的回顾性综述
5. Effect of intravitreal or sub-tenon triamcinolone acetonide injection at completion of vitrectomy on peripheral retinochoroidal thickness in eyes with proliferative diabetic retinopathy [D] . Fujiwara Yoshito, 藤原圭人 2019

机译：玻璃体切除术完成后玻璃体内或肌腱下注射丙酮酸曲安奈德对增生性糖尿病性视网膜病变的眼睛周围脉络膜脉络膜厚度的影响
6. Vitreous and Plasma VEGF Levels as Predictive Factors in the Progression of Proliferative Diabetic Retinopathy after Vitrectomy [O] . Jiaxing Wang, Song Chen, Feng Jiang, 2010

机译：玻璃体和血浆VEGF水平是玻璃体切除术后增生性糖尿病视网膜病变进展的预测因素
7. Vitreous and plasma VEGF levels as predictive factors in the progression of proliferative diabetic retinopathy after vitrectomy. [O] . Jiaxing Wang, Song Chen, Feng Jiang, 2014

机译：玻璃体切除术后玻璃体和血浆VEGF水平作为增殖性糖尿病视网膜病变进展的预测因素。

Vitreous and plasma cytokine levels in subjects with advanced proliferative diabetic retinopathy in the Ranibizumab in Diabetic Vitrectomy (RaDiVit) Study

著录项

相似文献

相关主题

期刊订阅